Ibrahim IS, et al. - In a magnetic resonance imaging (MRI)-based surveillance program for individuals at high risk (IARs) for pancreatic ductal adenocarcinoma (PDAC), the frequency and type of incidental findings were examined. Further, researchers assessed the benefit of detecting these lesions. From three long-term pancreas surveillance programs conducted at three large European expert centers, they reviewed MRI screening in 568 individuals. IARs for PDAC commonly display extrapancreatic incidentaloma, but rarely require additional treatment. A substantial number of cancers were noted among CDKN2A-p16-Leiden mutation carriers, and their detection was beneficial in several cases.